ArticleGut pathogens2018
Occurrence of multidrug-resistant and ESBL-producing atypical enteropathogenic
Article in Gut pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Antibiofilm Potential and Mechanisms ofMicroorganisms · 2026Article
- Occurrence of extended- spectrum β-lactamases and ertapenem- mono- resistance inOne health (Amsterdam, Netherlands) · 2025Article
- Prevalence of CTX-M types among ESBL-producing pathogenicFood science and biotechnology · 2024Article
- Rapid turnover and short-term blooms ofJournal of bacteriology · 2024Article
- Distribution of Extended-Spectrum-β-Lactamase-Producing DiarrheagenicAntibiotics (Basel, Switzerland) · 2023Article
- Extended-spectrum β-lactamase-producing Enterobacteriaceae from ready-to-eat foods: Genetic diversity and antibiotic susceptibility.Food science & nutrition · 2023Article
- A strategy design based on antibiotic‑resistance and plasmid replicons genes of clinical Escherichia coli strains.Bioengineered · 2022Article
- Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli-prospective traveller study with literature review.Journal of travel medicine · 2022Review
- Typical and atypical enteropathogenic Escherichia coli in children with acute diarrhoea: Changing trend in East Delhi.Biomedical journal · 2021Article
- Efficiency evaluation of some novel disinfectants and anti-bacterial nanocomposite on zoonotic bacterial pathogens in commercial Mallard duck pens for efficient control.Journal of advanced veterinary and animal research · 2021Article
- Antimicrobial Resistance of Non-O157 Shiga Toxin-ProducingAntibiotics (Basel, Switzerland) · 2021Article
- The first evaluation relationship of integron genes and the multidrug-resistance in class A ESBLs genes in enteropathogenic Escherichia coli strains isolated from children with diarrhea in Southwestern Iran.Molecular biology reports · 2021Article
- Quantitative analysis and virulence phenotypes of atypical enteropathogenicGut microbes · 2020Article
- Characterization of Antimicrobial Susceptibility, Extended-Spectrum β-Lactamase Genes and Phylogenetic Groups of EnteropathogenicOsong public health and research perspectives · 2020Article
- Whole Genome Sequencing Differentiates Presumptive Extended Spectrum Beta-Lactamase ProducingMicroorganisms · 2020Article
- High Frequency of Multidrug-Resistant (MDR) Atypical EnteropathogenicFrontiers in veterinary science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtypical enteropathogenic
resultsAmong 267 aEPEC isolates, 146 (54.7%) were resistant to tetracycline, followed by ampicillin (49.4%), streptomycin (46.1%), and piperacillin (41.2%). Multidrug resistance (MDR) was detected in 128 (47.9%) isolates, and 40 MDR isolates were resistant to ≥ 10 antimicrobial agents. A total of 47 (17.6%) aEPEC isolates were identified as extended-spectrum β-lactamase (ESBL)-producers. The
conclusionsThis investigation depicted the occurrence of multidrug-resistant and ESBL-producing aEPEC isolates in China. The results suggested that it is necessary to continuously monitor the emergence and spread of MDR aEPEC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.